INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
INTELLIGENT BIO SOLUTIONS INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026
$1.53+0.03 (+2.00%)
Close on Oct 19, 2026
- Market cap
- $3.83M
- P/E (TTM)
- –
- Dividend yield
- –
Intelligent Bio Solutions statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Market Cap | $4.63M | $230.55M |
| Enterprise Value | $419.71K | $202.97M |
| PS Ratio | 1.10 | 3.10 |
| PB Ratio | 0.84 | 3.04 |
| P/TBV Ratio | 1.71 | 4.43 |
Enterprise value
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| EV / Sales | 0.10 | 2.91 |
Income (trailing twelve months)
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Revenue | $4.22M | $102.39M |
| Gross Profit | $2.05M | $60.36M |
| Operating Income | -$12.61M | -$4.31M |
| Net Income | -$12.43M | -$6.57M |
| EBITDA | -$11.44M | -$1.98M |
| EPS (Diluted) | -$8.44 | -$0.08 |
Margins
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Gross Margin | 48.6% | 55.2% |
| Operating Margin | -299.1% | -6.04% |
| Profit Margin | -294.9% | -10.5% |
| EBITDA Margin | -271.5% | -2.67% |
| FCF Margin | -285.9% | 0.02% |
Returns
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Return on Equity (ROE) | -292.3% | -18.2% |
| Return on Assets (ROA) | -123.1% | -13.3% |
| Return on Invested Capital (ROIC) | -570.0% | -3.69% |
| Return on Capital Employed (ROCE) | -179.8% | -9.07% |
Growth
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 38.1% | 8.85% |
| Revenue Growth (3Y CAGR) | 49.7% | 7.08% |
| Revenue Growth (5Y CAGR) | 16.3% | 11.8% |
Balance sheet
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.99M | $36.66M |
| Net Cash (Debt) | $3.99M | $3.92M |
| Net Cash Per Share | $1.32 | $0.28 |
| Equity (Book Value) | $5.51M | $55.33M |
| Book Value Per Share | $1.82 | $2.87 |
| Tangible Book Value | $2.71M | $10.79M |
| Working Capital | $2.17M | $56.72M |
Financial position
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Current Ratio | 1.44 | 2.48 |
| Quick Ratio | 0.98 | 1.53 |
| Interest Coverage | -1174.37 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Operating Cash Flow | -$11.93M | -$566.22K |
| Capital Expenditures | -$125.73K | -$3.69M |
| Free Cash Flow | -$12.05M | -$696.00K |
| FCF Per Share | -$3.98 | -$0.02 |
Efficiency
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Asset Turnover | 0.42 | 0.58 |
| Inventory Turnover | 4.11 | 2.21 |
| Revenue Per Employee | $301.08K | $322.92K |
| Profits Per Employee | -$887.93K | -$51.88K |
| Employee Count | 14 | 185 |
Dividends and yields
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Earnings Yield | -268.4% | -6.88% |
| FCF Yield | -260.2% | -0.45% |
Shares
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Shares Outstanding | 3,027,470 | 44,302,700 |
| Shares Change (YoY) | 179.3% | 3.36% |
| Shares Change (QoQ) | 45.2% | 0.27% |
| Float | 2,937,000 | 37,462,700 |
| Shares Held by Insiders | 2.99% | 10.5% |
| Shares Held by Institutions | 5.99% | 63.5% |
Scores
| Measure | Intelligent Bio Solutions | Industry median |
|---|---|---|
| Altman Z-Score | -11.28 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.33 | -2.64 |
Calculated by StockData from Intelligent Bio Solutions's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.